In photodynamic therapy, a photosensitizing dye restrictively localized to certain sites in the biological milieu, is activated by visible light to selectively destroy the stained structure. Although primarily investigated for necroting malignant tumors, this approach also suggests potential in treating other pathological conditions such as age-related macular degeneration and atherosclerosis. Until recently, hematoporphyring derivative was practically the only dye investigated for photodynamic therapy. The use of phthalocyanine dyes is being explored as a superior alternative photosensitizer for treatment of these diseases.
|Number of pages
|Berichte der Bunsengesellschaft/Physical Chemistry Chemical Physics
|Published - 1989
|Discussion Meeting of The Deutsche Bunsen-Gesellschaft fuer Physikalische Chemie - Heildelberg, West Ger
Duration: 29 Aug 1988 → 1 Sep 1988
ASJC Scopus subject areas
- General Chemical Engineering